Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Oct;46(10 Pt B):e3-e6.
doi: 10.1016/j.ejso.2020.06.004. Epub 2020 Jun 14.

The drug treatment research of gastrointestinal cancer in China

Affiliations
Review

The drug treatment research of gastrointestinal cancer in China

Chao Ren et al. Eur J Surg Oncol. 2020 Oct.

Abstract

Gastrointestinal cancer is one of the most common cancers in China. Due to the late detection for most patients, the overall prognosis of gastrointestinal cancer is still poor. At present, the treatment of gastrointestinal cancer includes surgery, radiotherapy, ablation, chemotherapy, targeting, immunity and other treatment methods. Therefore, with the continuous improvement of individualized treatment, we hope to improve the effect of gastrointestinal cancer treatment by promoting the research progress of anti-tumor drugs. Although China's research in the field of gastrointestinal cancer drug treatment has only begun relatively recently, there has been rapid development in our progress. An increasing number of research studies led by Chinese researchers have attracted international attention, influencing clinical practices all over the world and adding to China's contribution to the global field of medicine. This article reviews China's main contributions in the clinical research of gastrointestinal cancer drugs in the past two years.

Keywords: China; Drug treatment research; Gastrointestinal cancer.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest We have no financial or personal relationships with other people or organizations that would bias our work. No benefits in any form have been received or will be received from a commercial party related directly or indirectly to the subject of our article.

MeSH terms

Substances

LinkOut - more resources